Health Care & Life Sciences » Biotechnology | Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.03
Market Cap
HKD469.84 M
Shares Outstanding
426 M
Public Float
-

Profile

Address
18th Floor, United Centre
Hong Kong
Hong Kong
Employees -
Website http://www.interlong.com
Updated 07/08/2019
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. It operates through the following segments: Manufacturing and Selling of Medicines; Sales and Distribution of Medicines and Healthcare Products; and Provision of Research and Development Services of Modern Biological Technology. The company was founded on November 15, 1994 and is headquartered in Hong Kong.

Financials

View All

Feng Zhang
Chairman & Compliance Officer
Yan He Xu
General Manager & Executive Director